Figure 1.
The Kaplan-Meier plots showing overall survival (A) and progression- free survival (B) in the whole cohort of 86 CML patients treated with dasatinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.